December 13, 2010

Biotech company Genzyme still is saying “no thanks” to French drug maker Sanofi-Aventis’ tender offer of $18.5 billion, or $69 per share, to acquire it, saying the offer “substantially undervalues” the company.

October 28, 2010

British drug maker GlaxoSmithKline will work with U.S.-based Amicus Therapeutics to develop a drug for...

October 3, 2010

French drug maker Sanofi-Aventis has launched a hostile takeover bid to take over Cambridge, Mass.-based...

September 27, 2010

The Food and Drug Administration has approved a generic version of a drug for a...

August 29, 2010

BioMarin Pharmaceutical on Monday announced its investigational treatment for a lysosomal storage disorder has received...

August 25, 2010

Biotech drug maker Genzyme’s takeover by French drug maker Sanofi-Aventis may have run into trouble,...

July 7, 2010

Generic drug maker Hospira will fill and package several drugs for Genzyme, according to published...

May 24, 2010

The Food and Drug Administration has approved a new treatment for a rare genetic disorder...

May 23, 2010

Biotech company Genzyme will pay $175 million to the federal government as part of an...

May 16, 2010

An investigational drug made by Teva Pharmaceutical Industries was not effective in patients with Lou...

March 23, 2010

Genzyme Corp. will have to submit to inspections of one of its plants by the...

February 25, 2010

The Food and Drug Administration has approved a new drug for treating a rare genetic...

February 2, 2010

The Food and Drug Administration has approved a drug for treating a debilitating hand condition...